Drug intelligence / Profile preview

albumin (human) + phenol + glycerin

Development stage
Unknown
Lead developer
Jubilant HollisterStier
Administration
Subcutaneous, Intradermal
01

Overview

**albumin (human) + phenol + glycerin** is a sterile biologic diluent solution used in allergen immunotherapy and allergy skin testing preparation, rather than a direct pharmacologically active therapeutic ingredient. It is used to prepare serial dilutions of allergenic extracts and to help preserve extract stability and potency during storage and administration. In this formulation, human serum albumin functions primarily as a protein stabilizer that reduces loss of allergen activity through adsorption and degradation, phenol serves as an antimicrobial preservative, and glycerin contributes additional stabilization and preservation of allergenic extracts. The product is associated with Jubilant HollisterStier and is used in the management workflow for patients with immediate hypersensitivity to specific allergens, including preparation of materials for diagnostic skin testing and allergen immunotherapy.

Brand names
Sterile Diluent for Allergenic Extract
Other names
albumin (human) + phenol + glycerinhuman serum albumin phenol glycerin diluentallergen diluent containing albumin (human), phenol, and glycerin

Beyond the preview

Go deeper on albumin (human) + phenol + glycerin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on albumin (human) + phenol + glycerin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call